Abiopharma

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Stepan Increases Quarterly Cash Dividend, Marking the 58th Consecutive Year of Increases

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

XORTX Announces Closing of US$1.1 Million Registered Direct Offering

EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma